# US Digital Therapeutics Market

> US Digital Therapeutics Market Research Report: Size, Share, Trend Analysis By Applications (Chronic Disease Management, Mental Health Disorders, Preventive Care, General Wellness), By Delivery Mode (Software, Device, Platform), By End Users (Patients, Providers, Payers, Employers) and By Therapeutic Area (Diabetes, Cardiology, Neurology, Oncology) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 21.34%
- **2024:** $ 2,800 Million
- **2025:** $ 3,397.52 Million
- **2035:** $ 23,500 Million
- **Key Players:** Omada Health (US), Pear Therapeutics (US), Big Health (US), Akili Interactive (US), DarioHealth (IL), WellDoc (US), Livongo Health (US), Mytonomy (US)

**Report ID:** MRFR/Pharma/16404-HCR · **Pages:** 100 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-digital-therapeutics-market-17932

---

## Market Summary

## **US Digital Therapeutics Market Overview**

As per MRFR analysis, the US Digital Therapeutics Market Size was estimated at 1.48 (USD Billion) in 2023. The US Digital Therapeutics Market Industry is expected to grow from 1.73 (USD Billion) in 2024 to 10.56 (USD Billion) by 2035. The US Digital Therapeutics Market CAGR (growth rate) is expected to be around 17.887% during the forecast period (2025 - 2035).

### **Key US Digital Therapeutics Market Trends Highlighted**

The US Digital Therapeutics Market is experiencing notable growth driven by an increasing prevalence of chronic diseases, such as diabetes and mental health disorders, which are becoming more prevalent in the population. The rise of telehealth solutions, accelerated by the COVID-19 pandemic, has further pushed demand for digital therapeutic interventions, as healthcare providers and patients seek remote management options.

The awareness and acceptance of digital health solutions among healthcare professionals and patients are also key market drivers. Numerous states have begun integrating digital therapeutics into standard care protocols, highlighting a shift towards more technology-driven healthcare solutions.

There are significant opportunities to be explored in the US Digital Therapeutics Market. The aging population offers a chance for the development of specific products targeting age-related health issues, such as cognitive decline and mobility problems. Furthermore, partnerships between tech firms and health organizations can lead to innovative solutions that further enhance user engagement.

As more payers begin to recognize the efficacy of digital therapeutics, reimbursement policies are evolving to include these solutions, providing a clear pathway for widespread adoption. Recent trends indicate that collaboration among stakeholders in the healthcare ecosystem, including technology companies, pharmaceutical firms, and healthcare providers, is increasing.

Innovations focus on personalized medicine, where digital therapies are tailored to individual patient profiles, enhancing effectiveness and user experience. Additionally, regulatory bodies are adapting to this market evolution by providing clearer guidance on the approval processes for digital therapeutics, which is crucial for fostering innovation while ensuring patient safety.

Overall, these trends suggest a robust future for the digital therapeutics landscape in the US, shaped by technology, collaboration, and regulatory support.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **US Digital Therapeutics Market Drivers**

### **Rising Prevalence of Chronic Diseases**

The US Digital Therapeutics Market Industry is set to grow significantly due to the increasing prevalence of chronic diseases such as diabetes, cardiovascular conditions, and mental health disorders. According to the Centers for Disease Control and Prevention (CDC), approximately 42% of adults in the United States have obesity, which is a major risk factor for various chronic diseases.

Furthermore, the CDC estimates that over 34 million Americans have diabetes, a number that has been steadily rising over the past decade. As healthcare practitioners and patients look for cost-effective and accessible management solutions, digital therapeutics are increasingly viewed as innovative tools for managing these conditions.

Major organizations such as Omada Health and Livongo Health are investing heavily in technologies aimed at addressing these issues, thereby further validating the growth potential of the US Digital Therapeutics Market.

### **Growing Demand for Remote Healthcare Solutions**

The ongoing shift towards telehealth and remote patient monitoring is acting as a significant driver for the US Digital Therapeutics Market Industry. According to a report from the American Hospital Association, approximately 76% of U.S. hospitals are now utilizing telehealth services, a substantial increase from previous years.

This trend has accelerated in response to the COVID-19 pandemic, with the U.S. Department of Health and Human Services reporting that telehealth visits increased by 154% during the last week of March 2020 compared to the previous year. As healthcare providers and patients embrace these remote care options, digital therapeutics are being integrated into these platforms to improve outcomes and enhance patient engagement.

Companies such as Pear Therapeutics and Happify Health are at the forefront of offering digital solutions that enhance remote healthcare experiences.

### **Increased Investment in Health Technology**

There has been a notable surge in venture capital investment in health technology, which is fueling the growth of the US Digital Therapeutics Market Industry. According to a report from Rock Health, 2021 saw record-breaking funding in digital health, with over $29 billion invested in the first three quarters alone.

This influx of capital is allowing digital therapeutics companies to innovate and expand their offerings, ultimately resulting in better therapeutic solutions for consumers. Initiatives by large healthcare entities like UnitedHealth Group and Cigna are further driving this investment trend, as they are not only investing in digital solutions but also actively promoting the use of digital therapeutics for chronic disease management.

This environment of increased financial support is a critical driver in establishing the US Digital Therapeutics Market as a robust industry in the healthcare landscape.

## **US Digital Therapeutics Market Segment Insights**

### **Digital Therapeutics Market Application Insights**

The US Digital Therapeutics Market is experiencing significant growth and evolution, particularly within the Application segment, which is crucial for addressing various health concerns through technology-enabled solutions. The Application segment can be categorized into different areas, including Chronic Disease Management, Mental Health Disorders, Preventive Care, and General Wellness, each of which plays a vital role in the healthcare landscape.

Chronic Disease Management is increasingly regarded as a priority area where digital therapeutics offer patients innovative methods to manage conditions such as diabetes, hypertension, and cardiovascular diseases, allowing for real-time monitoring and personalized treatment without constantly relying on traditional healthcare settings. On the other hand, Mental Health Disorders encompass a broad spectrum of conditions, including anxiety and depression, which have reached alarming levels in the US.

Digital therapeutics in this area aim to provide effective therapeutic interventions through mobile applications, fostering greater accessibility and reducing stigma associated with mental health treatment. Preventive Care is gaining traction as a proactive approach to health, utilizing digital health solutions to promote healthy lifestyles and prevent diseases before they become severe, thereby supporting long-term health improvements for the population.

General Wellness encompasses a range of applications focused on improving overall health, promoting physical activities, enhancing nutrition, and improving sleep quality, which are essential components of holistic health. The increasing adoption of mobile health applications, coupled with advancements in technology, is driving the growth within these Application areas.

Furthermore, the involvement of healthcare providers, insurers, and other stakeholders is becoming increasingly essential as they recognize the potential of digital therapeutics in facilitating patient engagement and improving treatment adherence. With the regulatory landscape becoming more supportive and the demand for remote health management continuing to rise, the prospects for each Application category within the US Digital Therapeutics Market are promising.

As awareness grows and technology evolves, the market is poised for continued expansion, with the digital health revolution reshaping patient care across the nation.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Digital Therapeutics Market Delivery Mode Insights**

The Delivery Mode segment of the US Digital Therapeutics Market is crucial for enabling tailored healthcare solutions, focusing on the ways these therapeutics are made accessible to patients. This segment encompasses three primary channels: Software, Device, and Platform, each playing a significant role in enhancing patient engagement and treatment adherence.

Software solutions typically offer mobile applications and web-based systems that facilitate real-time monitoring and therapeutic interventions, enhancing user experience and supporting chronic disease management. Devices, which include wearables and other hardware, provide critical data collection and feedback mechanisms that empower users to take charge of their health, thus fostering patient participation and compliance with therapy regimens.

Platforms serve as comprehensive ecosystems that integrate software and devices, streamlining workflows for healthcare providers while ensuring that patients receive consistent, personalized care. The continued evolution and adoption of these delivery modes are driven by the increasing demand for remote healthcare solutions and the emphasis on chronic disease management within the US healthcare landscape, illustrating the significance of this segment in advancing healthcare outcomes.

### **Digital Therapeutics Market End User Insights**

The US Digital Therapeutics Market exhibits a diverse End User landscape consisting of Patients, Providers, Payers, and Employers, each playing a pivotal role in the industry's growth. Patients represent a substantial segment as they increasingly adopt digital health solutions for managing chronic conditions, which significantly enhances treatment adherence and outcomes.

Providers, including physicians and healthcare institutions, are instrumental in integrating these solutions into standard care practices, driven by a demand for innovative therapies that improve patient engagement and result in better clinical outcomes. Payers, such as insurance companies, are adapting their frameworks to cover digital therapeutics, recognizing their potential to reduce overall healthcare costs by promoting preventive care and reducing hospital admissions.

Employers are also showing a keen interest in digital therapeutics as they seek to provide additional health benefits to their employees, which can lead to improved workforce health and productivity. This multi-faceted engagement among the End User categories signifies a growing recognition of the value of digital therapeutics in addressing healthcare challenges and improving access to innovative treatment options in the US.

### **Digital Therapeutics Market Therapeutic Area Insights**

The US Digital Therapeutics Market focusing on the Therapeutic Area segment is characterized by significant advancements, driven by increasing adoption of technology in healthcare and the rising prevalence of chronic diseases. The Diabetes sector is notably important as it addresses the growing number of individuals managing this condition, offering personalized treatment solutions that enhance patient engagement and outcomes.

Similarly, the Cardiology area holds a vital role due to the escalating rates of heart disease in the US, where digital therapies can provide patients with real-time monitoring and management tools. In Neurology, digital therapeutics are crucial in managing complex conditions such as epilepsy and multiple sclerosis, complementing traditional therapies with innovative solutions that can improve cognition and quality of life.

Meanwhile, Oncology is emerging as a significant segment, as digital therapeutics aid in symptom management, adherence to treatment, and emotional support for patients undergoing cancer therapies. With a robust focus on personalized care and preventive strategies, the Therapeutic Area within the US Digital Therapeutics Market is poised for growth, buoyed by ongoing technological advancements and increased health awareness.

This market showcases a blend of high demand for tailored therapeutic solutions and the opportunity for greater patient outcomes through digital innovation.

## **US Digital Therapeutics Market Key Players and Competitive Insights**

The US Digital Therapeutics Market has emerged as a dynamic and rapidly evolving sector within the broader healthcare landscape, driven by technological advancements and an increasing recognition of the importance of patient-centric care. As digital solutions increasingly take center stage, numerous companies are competing to offer innovative therapeutic interventions that leverage software to treat various medical conditions, from mental health disorders to chronic diseases.

Notable players in this market are differentiating themselves through unique digital offerings, regulatory approvals, and collaborations with healthcare providers. The competitive insights reveal a trend towards partnerships and a focus on clinically validated programs that transition traditional therapeutic methodologies into digital platforms, catering to both patients and healthcare systems.

### **MedRhythms**

MedRhythms has established a commendable presence within the US Digital Therapeutics Market, focusing on innovative therapeutic solutions utilizing music and rhythm-based interventions to address neurological conditions. The company's strengths lie in its evidence-based approach, having developed clinically validated products aimed at improving functions such as walking and mobility in patients with neurological diseases.

MedRhythms actively collaborates with various stakeholders in the healthcare ecosystem, including research institutions and healthcare providers, to enhance its offerings and ensure compliance with regulatory standards. The company’s unique positioning in the market helps it garner attention from healthcare professionals who seek alternative therapeutic approaches for patients requiring progressive rehabilitation solutions.

### **Pear Therapeutics**

Pear Therapeutics has also made significant strides in the US Digital Therapeutics Market with its commitment to developing prescription digital therapeutics that address a range of conditions, including substance use disorder and other behavioral health issues. The company boasts a robust portfolio of products that are clinically validated and prescribed by healthcare professionals as adjuncts to standard therapies.

Pear Therapeutics has established strategic partnerships and collaborations that have amplified its market reach and enhanced its service offerings, aligning itself with leading healthcare providers and payers. Notably, the company has engaged in mergers and acquisitions to bolster its technological capabilities and expand its product pipeline, positioning itself as a leader in this rapidly evolving space.

With a focus on regulatory compliance and evidence-based solutions, Pear Therapeutics is actively contributing to the development of digital therapies that seamlessly integrate into existing treatment paradigms for patients across the United States.

### **Key Companies in the US Digital Therapeutics Market Include**

- [**MedRhythms**](https://medrhythms.com/digital-therapeutics-using-direct-auditory-stimulation-pioneering-approaches-to-healthcare-delivery/)
- Pear Therapeutics
- Omada Health
- Lumiata
- Myndshift
- Dthera Sciences
- WellDoc
- Akili Interactive
- Happify Health
- Noom
- Zebra Health
- Big Health
- Click Therapeutics
- PsychoGenics

## **US Digital Therapeutics Market Industry Developments**

Recent developments in the US Digital Therapeutics Market have showcased a growing momentum among key players such as MedRhythms, Pear Therapeutics, and Omada Health, particularly in the wake of increased regulatory support and rising demand post-pandemic. In September 2023, Dthera Sciences announced updates to their product offerings aimed at enhancing mental health interventions, emphasizing the market's focus on behavioral health solutions.

Additionally, in August 2023, WellDoc launched a new version of its diabetes management platform, contributing to increased awareness among healthcare providers. Notable acquisitions include Akili Interactive's acquisition of a digital therapeutics platform in July 2023, enhancing their cognitive behavioral therapy offerings.

Pear Therapeutics experienced a valuation increase following a funding round that attracted significant investment. The US Digital Therapeutics Market is projected to grow considerably as healthcare systems integrate these technologies into traditional treatment plans, fostering collaboration across various sectors.

The expansion in digital health tools has resulted in a shift in therapeutic approaches, with companies like Noom and Happify Health gaining traction by focusing on holistic health solutions. The regulatory landscape continues to evolve, providing clarity and support for innovative therapeutic solutions in the realm of mental health and chronic disease management.

## **US Digital Therapeutics Market Segmentation Insights**

### **Digital Therapeutics Market Application Outlook**

- Chronic Disease Management
- Mental Health Disorders
- Preventive Care
- General Wellness

### **Digital Therapeutics Market Delivery Mode Outlook**

- Software
- Device
- Platform

### **Digital Therapeutics Market End User Outlook**

- Patients
- Providers
- Payers
- Employers

### **Digital Therapeutics Market Therapeutic Area Outlook**

- Diabetes
- Cardiology
- Neurology
- Oncology

## Market Drivers

### Growing Focus on Preventive Healthcare

The digital therapeutics market is witnessing a growing emphasis on preventive healthcare strategies. As healthcare costs continue to escalate, there is a concerted effort to shift from reactive to proactive health management. Digital therapeutics provide tools that empower individuals to take charge of their health, potentially reducing the incidence of chronic diseases. In the US, preventive healthcare initiatives are gaining traction, with a reported increase in the use of digital solutions for lifestyle modifications. This shift is expected to drive the digital therapeutics market, as more individuals seek out interventions that promote wellness and prevent disease onset. The potential for cost savings and improved public health outcomes further underscores the importance of this trend in shaping the future of healthcare.

### Technological Advancements in Healthcare

Technological advancements are playing a pivotal role in shaping the digital therapeutics market. Innovations in artificial intelligence, machine learning, and data analytics are enabling the development of more sophisticated therapeutic solutions. These technologies facilitate personalized treatment plans that adapt to individual patient needs, thereby enhancing engagement and efficacy. In the US, the integration of advanced technologies is projected to increase the market's value significantly, with estimates suggesting a growth rate of over 25% annually. Furthermore, the ability to collect and analyze real-time data allows for continuous monitoring and timely interventions, which are crucial for effective treatment. As healthcare providers increasingly adopt these technologies, the digital therapeutics market is likely to expand, offering new opportunities for both patients and providers.

### Rising Demand for Chronic Disease Management

The digital therapeutics market is experiencing a notable surge in demand for solutions aimed at chronic disease management. As the prevalence of chronic conditions such as diabetes and hypertension continues to rise, healthcare providers are increasingly seeking innovative ways to support patient care. In the US, approximately 60% of adults live with at least one chronic disease, which underscores the necessity for effective management tools. Digital therapeutics offer personalized interventions that can enhance patient adherence and improve health outcomes. This trend is likely to drive investment in digital health technologies, as stakeholders recognize the potential for cost savings and improved quality of life for patients. Consequently, the digital therapeutics market is poised for substantial growth as it aligns with the evolving needs of healthcare systems and patients alike.

### Regulatory Support and Reimbursement Policies

Regulatory support and favorable reimbursement policies are emerging as critical drivers for the digital therapeutics market. The US government and regulatory bodies are increasingly recognizing the importance of digital health solutions, leading to the establishment of frameworks that facilitate their integration into standard care. Recent initiatives have aimed to streamline the approval process for digital therapeutics, making it easier for developers to bring their products to market. Additionally, reimbursement policies are evolving to include digital therapeutics, which enhances their accessibility and adoption among healthcare providers. This supportive regulatory environment is likely to bolster the digital therapeutics market, as it encourages innovation and ensures that patients can benefit from these advanced solutions.

### Increased Investment from Healthcare Stakeholders

Investment in the digital therapeutics market is on the rise, driven by a growing recognition of the value these solutions bring to healthcare. Venture capital funding and partnerships between technology firms and healthcare providers are becoming more prevalent, as stakeholders seek to capitalize on the potential of digital therapeutics. In the US, funding for digital health startups has reached unprecedented levels, with estimates indicating an influx of over $10 billion in recent years. This financial backing is likely to accelerate innovation and the development of new therapeutic solutions, thereby expanding the market. As healthcare stakeholders continue to invest in digital therapeutics, the industry is expected to evolve rapidly, offering a wider array of solutions to meet diverse patient needs.

## Future Outlook

The [Digital Therapeutics Market](https://www.marketresearchfuture.com/reports/digital-therapeutics-market-6492) is projected to grow at a 21.34% CAGR from 2025 to 2035, driven by technological advancements, increasing chronic diseases, and rising healthcare costs.

**New opportunities:**

- Partnerships with healthcare providers for integrated care solutions. Development of subscription-based models for continuous patient engagement. Investment in AI-driven analytics for personalized treatment plans.

By 2035, the market is expected to achieve substantial growth, driven by innovation and strategic partnerships.

## Segment Insights

### By Application: Chronic Disease Management (Largest) vs. Mental Health Disorders (Fastest-Growing)

In the US digital therapeutics market, the application segment demonstrates a diverse distribution of market share among its key values. Chronic Disease Management holds the largest share, illustrating its significant role in addressing the healthcare needs of patients with ongoing health issues. Conversely, Mental Health Disorders is becoming increasingly impactful, capitalizing on the growing awareness and demand for mental health solutions, thus capturing a substantial and growing market share. The growth trends within the application segment are driven by a blend of technological advancements and societal shifts. The rise in chronic illnesses is leading to heightened investment in Chronic Disease Management solutions, while the Mental Health Disorders segment is witnessing rapid growth fueled by the destigmatization of mental health issues and increased attention from healthcare providers. As consumers demand more accessible and effective therapeutic [solutions](../../../reports/patient-access-solutions-market-7811), these segments are poised for further expansion, supported by innovations in digital health technologies.

Chronic Disease Management (Dominant) vs. Mental Health Disorders (Emerging)

Chronic Disease Management represents the dominant force within the application segment, characterized by a broad array of digital solutions designed to assist patients in managing long-term health conditions. This includes tailored software for monitoring health metrics, medication adherence tools, and remote patient monitoring capabilities. On the other hand, Mental Health Disorders stands out as an emerging segment through digital interventions focused on mental wellness, anxiety management, and cognitive therapies. This segment is rapidly gaining traction as more individuals seek solutions for mental health challenges, spurred by the growing awareness of mental health importance and the integration of personalized therapeutic approaches. Both segments highlight a significant shift towards more patient-centric, technology-driven healthcare models.

### By Delivery Mode: Software (Largest) vs. Device (Fastest-Growing)

The US digital therapeutics market is characterized by a diverse range of delivery modes, primarily software, devices, and platforms. Currently, software holds the largest market share, benefiting from widespread adoption among healthcare providers and patients alike due to its accessibility and ease of use. Devices are emerging as a significant segment as well, particularly with the rise of wearables and connected health devices that allow for real-time patient monitoring and intervention. In terms of growth trends, the software segment continues to expand rapidly, driven by the increasing demand for personalized and remote healthcare solutions. Meanwhile, the device segment is noted for being the fastest-growing, propelled by advances in technology and the growing acceptance of digital health interventions. This growth is further supported by regulatory approvals and increased investments in health technology, confirming the trajectory towards a more integrated approach to health management.

Software (Dominant) vs. Device (Emerging)

The software segment in the US digital therapeutics market is dominant due to its scalability and user-friendly nature, providing solutions that can easily be integrated into existing healthcare systems. Software applications are extensively utilized for various therapeutic areas, including mental health, chronic disease management, and rehabilitation. Conversely, the device segment is emerging, characterized by innovations in health technology such as mobile health devices and wearable sensors that offer interactive health management. These devices facilitate continuous monitoring and have become increasingly popular among patients seeking more engaged health management solutions. While software leads in market share, devices are poised for rapid growth, indicating a potential shift in consumer preferences towards more interactive and connected health solutions.

### By End User: Patients (Largest) vs. Providers (Fastest-Growing)

In the US digital therapeutics market, the distribution among end users reveals that patients currently hold the largest share, significantly outpacing the other segments. Providers follow as the second largest segment, while payers and employers contribute to the overall landscape but with smaller shares. This segmentation reflects the increasing acceptance of digital therapeutics among patients seeking more personalized healthcare solutions, which is reshaping the market dynamics. Growth trends indicate a robust expansion, especially among providers who are rapidly adopting digital therapeutics to enhance patient care and streamline treatment processes. The demand is driven by the need for cost-effective solutions and improved patient engagement. Moreover, technological advancements and increasing healthcare integration are facilitating this growth, making providers a focus point for future developments in the market.

Patients (Dominant) vs. Providers (Emerging)

Patients represent the dominant segment in the US digital therapeutics market, driven by their direct engagement with digital health solutions aimed at self-managing chronic conditions and enhancing overall wellness. This segment benefits from a growing trend of personalized healthcare, where apps and platforms provide tailored therapeutic interventions. On the other hand, providers are emerging as a dynamic force in the market, utilizing digital therapeutics to streamline clinical workflows and improve patient outcomes. As telehealth becomes more integrated into standard care models, providers are increasingly recognizing the value of these solutions in enhancing their service offerings. The collaboration between patients and providers is pivotal in fostering an ecosystem where digital therapeutics can thrive, ensuring accessibility and effectiveness in treatment delivery.

### By Therapeutic Area: Diabetes (Largest) vs. Neurology (Fastest-Growing)

The US digital therapeutics market is characterized by a diverse array of therapeutic areas, with diabetes leading the way in market share. This segment continues to attract significant investment and consumer interest due to the increasing prevalence of diabetes and the demand for effective management solutions. In contrast, neurology is emerging quickly, fueled by technological innovations and the necessity for personalized treatments that meet the needs of patients with neurological disorders. Growth trends in this segment reflect a convergence of technological advancements and evolving healthcare needs. The rising adoption of smartphone applications, wearable devices, and AI-driven solutions in diabetes management is driving sustained demand. Meanwhile, the neurology sector is gaining momentum as awareness of mental health challenges and neurodegenerative diseases rises, creating substantial opportunities for digital therapeutic interventions to play a pivotal role in improving patient care.

Diabetes (Dominant) vs. Neurology (Emerging)

In the US digital therapeutics market, diabetes stands out as the dominant therapeutic area, accounting for a significant portion of users seeking innovative solutions for managing their condition. Digital therapeutics for diabetes typically involve personalized management plans, behavioral therapies, and continuous monitoring, enabling patients to achieve better health outcomes. In contrast, neurology represents an emerging segment, characterized by rapidly developing digital solutions addressing cognitive disorders, mental health issues, and chronic pain management. This area is witnessing increased investment and research-driven initiatives aimed at creating effective therapeutic solutions for neurological patients, making it a vital focus for future market growth.

## Competitive Benchmarking

The digital therapeutics market is currently characterized by a dynamic competitive landscape, driven by technological advancements and an increasing focus on personalized healthcare solutions. Key players such as Omada Health (US), Pear Therapeutics (US), and Akili Interactive (US) are at the forefront, each adopting distinct strategies to enhance their market positioning. Omada Health (US) emphasizes a data-driven approach, leveraging analytics to tailor interventions for chronic disease management, while Pear Therapeutics (US) focuses on developing prescription digital therapeutics that integrate seamlessly with traditional healthcare practices. Akili Interactive (US), on the other hand, is pioneering the use of video game technology to treat cognitive disorders, showcasing a unique intersection of entertainment and health that could redefine patient engagement. In terms of business tactics, companies are increasingly localizing their operations to better serve regional markets, optimizing supply chains to enhance efficiency and responsiveness. The competitive structure of the market appears moderately fragmented, with a mix of established players and emerging startups vying for market share. This fragmentation allows for diverse approaches to digital therapeutics, fostering innovation while also creating challenges in terms of market penetration and brand recognition. In October 2025, Omada Health (US) announced a strategic partnership with a major health insurer to expand its digital chronic care management program. This collaboration is expected to enhance patient access to Omada's services, potentially increasing its user base significantly. The strategic importance of this partnership lies in its ability to integrate digital therapeutics into existing healthcare frameworks, thereby improving patient outcomes and reducing overall healthcare costs. In September 2025, Pear Therapeutics (US) launched a new digital therapeutic aimed at treating substance use disorders, which has garnered attention for its innovative approach. This launch not only diversifies Pear's product offerings but also positions the company as a leader in addressing critical public health issues. The significance of this move is underscored by the growing recognition of digital solutions in managing complex behavioral health challenges. In August 2025, Akili Interactive (US) secured a $50M funding round to accelerate the development of its cognitive treatment platform. This influx of capital is likely to bolster Akili's research and development efforts, enabling the company to enhance its product offerings and expand its market reach. The strategic importance of this funding is evident in its potential to drive innovation and maintain competitive differentiation in a rapidly evolving market. As of November 2025, current trends in the digital therapeutics market include a pronounced shift towards digitalization, with an emphasis on integrating artificial intelligence (AI) into therapeutic solutions. Strategic alliances are increasingly shaping the competitive landscape, as companies recognize the value of collaboration in enhancing their technological capabilities. Looking ahead, competitive differentiation is expected to evolve, with a greater focus on innovation and technology rather than price-based competition. This shift suggests that companies that prioritize sustainable practices and reliable supply chains will likely emerge as leaders in the digital therapeutics market.

## Recent News & Developments

Recent developments in the US Digital Therapeutics Market have showcased a growing momentum among key players such as MedRhythms, Pear Therapeutics, and Omada Health, particularly in the wake of increased regulatory support and rising demand post-pandemic. In September 2023, Dthera Sciences announced updates to their product offerings aimed at enhancing mental health interventions, emphasizing the market's focus on behavioral health solutions.

Additionally, in August 2023, WellDoc launched a new version of its diabetes management platform, contributing to increased awareness among healthcare providers. Notable acquisitions include Akili Interactive's acquisition of a digital therapeutics platform in July 2023, enhancing their cognitive behavioral therapy offerings.

Pear Therapeutics experienced a valuation increase following a funding round that attracted significant investment. The US Digital Therapeutics Market is projected to grow considerably as healthcare systems integrate these technologies into traditional treatment plans, fostering collaboration across various sectors.

The expansion in digital health tools has resulted in a shift in therapeutic approaches, with companies like Noom and Happify Health gaining traction by focusing on holistic health solutions. The regulatory landscape continues to evolve, providing clarity and support for innovative therapeutic solutions in the realm of mental health and chronic disease management.

## Report Scope

| MARKET SIZE 2024 | 2800.0(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 3397.52(USD Million) |
| MARKET SIZE 2035 | 23500.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 21.34% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Omada Health (US), Pear Therapeutics (US), Big Health (US), Akili Interactive (US), DarioHealth (IL), WellDoc (US), Livongo Health (US), Mytonomy (US) |
| Segments Covered | Application, Delivery Mode, End User, Therapeutic Area |
| Key Market Opportunities | Integration of artificial intelligence in digital therapeutics enhances personalized treatment and patient engagement. |
| Key Market Dynamics | Rising demand for personalized digital therapeutics solutions driven by evolving consumer preferences and regulatory support. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What was the market valuation of the US digital therapeutics market in 2024?**
A: The market valuation was $2800.0 Million in 2024.

**Q: What is the projected market valuation for the US digital therapeutics market by 2035?**
A: The projected valuation for 2035 is $23500.0 Million.

**Q: What is the expected CAGR for the US digital therapeutics market during the forecast period 2025 - 2035?**
A: The expected CAGR is 21.34% during the forecast period 2025 - 2035.

**Q: Which therapeutic areas are expected to drive growth in the US digital therapeutics market?**
A: Key therapeutic areas include Neurology, Cardiology, Diabetes, and Oncology.

**Q: What are the main segments of the US digital therapeutics market?**
A: The main segments include Application, Delivery Mode, and End User.

**Q: How did the Chronic Disease Management segment perform in 2024?**
A: The Chronic Disease Management segment was valued at $800.0 Million in 2024.

**Q: What is the projected value of the Mental Health Disorders segment by 2035?**
A: The projected value for the Mental Health Disorders segment is $7000.0 Million by 2035.

**Q: Which delivery mode segment had the highest valuation in 2024?**
A: The Platform delivery mode segment had the highest valuation at $1400.0 Million in 2024.

**Q: Who are the key players in the US digital therapeutics market?**
A: Key players include Omada Health, Pear Therapeutics, Big Health, and Akili Interactive.

**Q: What was the valuation of the Device delivery mode segment in 2024?**
A: The Device delivery mode segment was valued at $840.0 Million in 2024.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-digital-therapeutics-market-17932*